Reading MOBX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MOBX free→Reading MOBX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track MOBX free→QuarterlyIQ Insights · MOBX
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. Business Update Mobix Labs, Inc. (the “Company”) is providing the following business update regarding certain previously disclosed and anticipated corporate matters. Vision Aerial Letter of Intent and Ongoing Negotiations As previously announced, the Company has entered into a non-binding letter of intent with Vision Aerial, Inc. (“Vision Aerial”) regarding a potential acquisition of Vision Aerial by the Company. The Company is currently engaged in active negotiations with Visio…
Creation of a Direct Financial Obligation. The information set forth under
Entry into a Material Definitive Agreement. First Amendment to Securities Purchase Agreement and Convertible Note and Investor Rights Agreement On May 13, 2026, Mobix Labs, Inc. (the “Company”) entered into a first amendment to the securities purchase agreement and senior secured convertible promissory note (the “First Amendment”), with Leviston Resources, LLC (“Leviston”), amending the senior secured convertible note originally issued on March 31, 2026 (the “Original Note”) to increase the p…
Unregistered Sales of Equity Securities The information set forth under Items 1.01 and 1.02 of this Current Report on Form 8-K is incorporated herein by reference. Between May 12, 2026 and May 18, 2026, Leviston converted the entire $4 million of outstanding principal under the Original Note, as amended, together with all accrued interest thereon, into an aggregate of 2,500,000 shares of Common Stock (the “Shares”), satisfying the Original Note in full. The issuance of the Shares was exempt f…
Termination of a Material Definitive Agreement. On May 18, 2026, the Company satisfied in full the entire $4 million of outstanding principal under the Original Note, together with all accrued interest thereon, through the conversion of such amounts into shares of Common Stock. Upon such full satisfaction, the Original Note, the Securities Purchase Agreement, dated March 31, 2026, between the Company and Leviston (as amended by the First Amendment), and the Registration Rights Agreement, date…
Material Modification to Rights of Security Holders. On April 2, 2026, Mobix Labs, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which became effective at 4:00 p.m. Eastern Time on April 6, 2026, and implemented a one-for-ten (1:10) reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding s…
Creation of a Direct Financial Obligation. The information set forth under
Entry into a Material Definitive Agreement. Securities Purchase Agreement, Convertible Note and Registration Rights Agreement On March 31, 2026, Mobix Labs, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Leviston Resources, LLC, a Delaware limited liability company (“Leviston”). Pursuant to the Securities Purchase Agreement, Leviston purchased from the Company a senior secured convertible promissory note in the original principal a…
Unregistered Sales of Equity Securities The information set forth under
Entry into a Material Definitive Agreement. On January 6, 2026, Mobix Labs, Inc., a Delaware corporation (the “ Company ”) entered into certain securities purchase agreements (the “ Purchase Agreements ”) with the investors listed on the signature pages thereto, relating to a public offering of 30,000,000 shares (the “ Shares ”) of the Company’s Class A common stock, par value $0.00001 per share (the “ Common Stock ”), at a price to the public of $0.20 per share (the “ Offering ”). In connect…
Results of Operations and Financial Condition. On December 1, 2025, Mobix Labs, Inc. issued a press release announcing its financial results for its fiscal year September 30, 2025. A copy of the press release is furnished as Exhibit 99.1. The information furnished under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported on May 2, 2025, the Company received a written notice on April 28, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum bid-price requirement for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid-Price Requireme…
of this Current Report on Form 8-K, on October 24, 2025, the Company entered into amendments to certain outstanding warrants held by Armistice Capital Master Fund Ltd. (“Armistice”). The warrants had previously been classified as liabilities on the Company’s balance sheet in the amount of approximately $6.3 million. The amendments modified certain terms so that, under applicable accounting guidance, the warrants are classified as equity rather than liabilities. As a result, this amount is now…
Entry into a Material Definitive Agreement. On October 21, 2025, Mobix Labs, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with Roth Capital Partners, LLC (“Manager”) under which the Company may offer and sell, from time to time at its sole discretion, up to $15.8 million in shares of its Class A common stock, $0.00001 par value per share (“Common Stock”), through the Manager acting in its capacity as its sales agent. Pursuant to the Agreement, sales…
Entry into a Material Definitive Agreement. On September 3, 2025, Mobix Labs, Inc., a Delaware corporation (the “Company”), entered into a warrant exercise inducement offer letter (the “Inducement Letter”) with a holder (the “Holder”) of warrants to purchase shares of the Company’s common stock (the “Existing Warrants”) pursuant to which the Holder agreed to exercise for cash their Existing Warrants to purchase up to an aggregate of 5,486,467 shares of the Company’s common stock, consisting o…
Unregistered Sales of Equity Securities. The Company issued the Inducement Warrants, the Existing Warrant Shares and the Placement Agent Warrants pursuant to the exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), available under Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder and intends to issue the Inducement Warrant Shares and shares issuable upon exercise of the Placement Agent Warrants pursuant to the s…
Unregistered Sales of Equity Securities. On August 13 and August 15, 2025, Mobix Labs, Inc. (the “Company”) completed a series of financing transactions that enhance the Company’s working capital position and provide additional financial flexibility. Lendspark Financing The Company entered into a Securities Purchase Agreement with Lendspark Corporation, pursuant to which it issued a secured promissory note (the “Note”) in the principal amount of $550,000. The Note bears a fixed annual interes…
Unregistered Sales of Equity Securities. On August 13 and August 15, 2025, Mobix Labs, Inc. (the “Company”) completed a series of financing transactions that enhance the Company’s working capital position and provide additional financial flexibility. Lendspark Financing The Company entered into a Securities Purchase Agreement with Lendspark Corporation, pursuant to which it issued a secured promissory note (the “Note”) in the principal amount of $550,000. The Note bears a fixed annual interes…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) On August 8, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as a Class I director of the Board effective immediately for a term expiring at the 2028 Annual Meeting of Stockholders. Mr. Sansone currently serves as Chief Executive Officer (“CEO”) of the Company. Prior to his appointment as…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) Departure of Certain Officers and Directors On July 23, 2025, Mobix Labs, Inc. (the “Company”) announced that Fabian Battaglia, Chief Executive Officer (“CEO”) and a named executive officer of the Company, notified the Company of his decision to step down from his role as CEO, effective July 25, 2025. Mr. Battaglia also informed the Company he…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Certain Officers On July 23, 2025, Mobix Labs, Inc. (the “Company”) announced that Fabian Battaglia, Chief Executive Officer (“CEO”) and a named executive officer of the Company, notified the Company of his decision to step down from his role as CEO, effective July 25, 2025. Mr. Battaglia will remain actively involved with the Company…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 28, 2025, Mobix Labs, Inc. (the “Company”) received two delinquency notification letters (the “Notices”) from the Listing Qualifications Staff (the “Staff”) of Nasdaq stating that the Company was not in compliance with the minimum bid price requirement and the market value of listed securities requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (c) On April 10, 2025, the Board of Directors (the “Board”) of Mobix Labs, Inc. (the “Company”) appointed Philip Sansone as Interim Chief Executive Officer of the Company, effective immediately. Mr. Sansone will serve as Interim Chief Executive Officer of the Company until Fabian Battaglia, currently on sick leave, is able to return to his position…
Unregistered Sales of Equity Securities. As described above, the Company has agreed to issue the Common Warrants and the Placement Agent Warrants pursuant to the exemption from the registration requirements of the Securities Act, available under Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder and intends to issue the Common Warrant Shares and shares of Common Stock underlying the Placement Agent Warrants pursuant to the same exemption. The description of the Common W…
Entry into a Material Definitive Agreement. On April 4, 2025, Mobix Labs, Inc., a Delaware corporation (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with a purchaser, pursuant to which the Company agreed to sell, in a registered direct offering (the “ Registered Direct Offering ”), an aggregate of 3,850,000 shares (the “ Shares ”) of the Company’s Class A common stock, $0.00001 par value per share (the “ Common Stock ”) and pre-funded warrants to…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.